Discover how MedAsia is pioneering at-home healthcare solutions as the industry shifts towards decentralized care. With a robust product portfolio and regulatory expertise, MedAsia partners with businesses for sustainable growth in this evolving market. Are you ready to take advantage of this opportunity?

Discover the critical changes coming with the MDR Reform at Year-End that aim to enhance patient safety and streamline compliance. Key revisions will focus on reducing administrative burdens, improving certification predictability, and fostering international cooperation. Will these changes restore the EU's appeal as a hub for innovative medical devices?

Achieve 80% cost reduction—from $25 to $5 per test—using the Mission® Cholesterol Meter, which delivers lab-accurate results in just 3 minutes. Boost patient follow-up by 60% while unlocking new revenue streams, and empower patients with immediate, accessible health insights. 

By 2025, medical device importers and distributors will face one of the most significant regulatory shifts in decades. The European Union's MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation) deadlines are closing in, while the U.S.